Company: IPCX
Filing Date: 2025-04-25
Form Type: 424B4
Source: 0001213900-25-035659
Chunk: 4

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-04-25
Form: 424B4
Chunk 4
---
lection Point Fund’s investment committee prior to the closing of our initial business combination. Accordingly, if Inflection Point Fund’s investment committee does not give its approval, Inflection Point Fund will not be obligated to make such investment. Further, we have the right, in our sole discretion, to reduce the amount of or decline such investment. We expect that the terms of any such PIPE transaction will be negotiated with the applicable business combination target and investors (including Inflection Point Fund), at the time a business combination agreement is signed. As a result of additional costs in connection with such anticipated PIPE transaction, we are entitled to withdraw a maximum of $250,000 of funds from interest earned on the trust account for working capital purposes per year (plus the rollover of unused amounts from prior years). Currently, there is no public market for our units, Class A ordinary shares or rights. We have been approved to have our units listed on The Nasdaq Global Market (“Nasdaq”), under the symbol “IPCXU.” The Class A ordinary shares and rights comprising the units will begin separate trading on the 52 ndday following the date of this prospectus unless Cantor Fitzgerald & Co., the representative of the underwriters, informs us of its decision to allow earlier separate trading, subject to our satisfaction of certain conditions as described further herein. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights will be listed on Nasdaq under the symbols “IPCX” and “IPCXR”, respectively.

We are an “emerging growth company” and a “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 46 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings. Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                                        |     | Per Unit |       |     | Total |             |
|:---------------------------------------|:----|:---------|------:|:----|:------|------------:|
| Public offering price                  |     | $        | 10.00 |     | $     | 220,000,000 |
| Underwriting discounts and commissions